2443 — Lead Data Balance Sheet
0.000.00%
HealthcareSpeculativeMicro Cap
Annual balance sheet for Lead Data, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
C2018 December 31st | 2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Interim Report | Annual Audited Accounts | Interim Report | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 324 | 183 | 209 | 361 | 282 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 98.9 | 108 | 81.9 | 13.2 | 62 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,343 | 612 | 514 | 413 | 426 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 351 | 431 | 193 | 165 | 62.4 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,916 | 1,328 | 846 | 646 | 538 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 832 | 322 | 258 | 188 | 53.4 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 923 | 434 | 360 | 267 | 83.3 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 993 | 893 | 487 | 379 | 455 |
| Total Liabilities & Shareholders' Equity | 1,916 | 1,328 | 846 | 646 | 538 |
| Total Common Shares Outstanding |